Form 4: Insmed Director McGirr Acquires 5,058 Restricted Stock Units

Director David W.J. McGirr acquired 5,058 Restricted Stock Units (RSUs) in Insmed Inc. on May 15, 2025, increasing his total holdings to 103,973 shares.

Summary

• On May 15, 2025, David W.J. McGirr, a director of Insmed Inc., acquired 5,058 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Insmed's common stock.
• The RSUs vest after one year, contingent upon McGirr remaining a board member and attending at least 75% of board meetings.
• The acquisition increased McGirr's total holdings to 103,973 shares of common stock.
• The RSUs were granted for no consideration.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director generally indicates confidence in the company's prospects, but it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest after one year, contingent upon McGirr remaining a board member and attending at least 75% of board meetings, suggesting a commitment to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Insmed, Director, RSU, Restricted Stock Units, Beneficial Ownership, Form 4, McGirr, Equity